16.75
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$16.76
Offen:
$16.7
24-Stunden-Volumen:
1.99M
Relative Volume:
0.48
Marktkapitalisierung:
$2.51B
Einnahmen:
$5.75B
Nettoeinkommen (Verlust:
$77.00M
KGV:
34.18
EPS:
0.49
Netto-Cashflow:
$-675.00M
1W Leistung:
+6.96%
1M Leistung:
+34.86%
6M Leistung:
+19.99%
1J Leistung:
-2.33%
Chemours Company Stock (CC) Company Profile
Firmenname
Chemours Company
Sektor
Branche
Telefon
302 773 1000
Adresse
1007 MARKET STREET, WILMINGTON, DE
Vergleichen Sie CC mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
CC
Chemours Company
|
16.75 | 2.44B | 5.75B | 77.00M | -675.00M | 0.49 |
![]()
LIN
Linde plc Ordinary Share
|
482.04 | 221.65B | 33.25B | 6.89B | 5.07B | 14.06 |
![]()
SHW
Sherwin Williams Co
|
360.10 | 89.12B | 23.08B | 2.54B | 2.15B | 10.08 |
![]()
ECL
Ecolab Inc
|
272.62 | 76.32B | 15.72B | 2.16B | 1.57B | 7.49 |
![]()
APD
Air Products Chemicals Inc
|
292.82 | 63.98B | 12.06B | 1.61B | -4.63B | 6.95 |
![]()
DD
Dupont De Nemours Inc
|
77.29 | 31.86B | 12.61B | 109.00M | 1.32B | -0.47 |
Chemours Company Stock (CC) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-03-27 | Hochstufung | Mizuho | Neutral → Outperform |
2025-01-28 | Eingeleitet | Truist | Buy |
2024-07-09 | Hochstufung | UBS | Neutral → Buy |
2024-06-07 | Eingeleitet | Mizuho | Neutral |
2024-04-09 | Hochstufung | BMO Capital Markets | Underperform → Outperform |
2024-03-05 | Herabstufung | UBS | Buy → Neutral |
2024-02-29 | Herabstufung | BMO Capital Markets | Outperform → Underperform |
2023-12-01 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
2023-06-22 | Herabstufung | BofA Securities | Buy → Neutral |
2023-01-24 | Hochstufung | UBS | Neutral → Buy |
2023-01-11 | Hochstufung | BofA Securities | Neutral → Buy |
2023-01-10 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
2022-11-01 | Eingeleitet | Credit Suisse | Underperform |
2022-10-13 | Eingeleitet | Goldman | Neutral |
2022-10-05 | Herabstufung | Argus | Buy → Hold |
2022-06-14 | Herabstufung | BofA Securities | Buy → Neutral |
2021-06-10 | Eingeleitet | Wolfe Research | Outperform |
2021-06-09 | Hochstufung | Goldman | Neutral → Buy |
2021-05-20 | Eingeleitet | BofA Securities | Buy |
2021-05-06 | Hochstufung | Argus | Hold → Buy |
2021-01-08 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
2020-12-04 | Herabstufung | Barclays | Overweight → Equal Weight |
2020-11-30 | Eingeleitet | Alembic Global Advisors | Overweight |
2020-03-23 | Herabstufung | Jefferies | Buy → Hold |
2020-02-14 | Hochstufung | CFRA | Buy → Strong Buy |
2019-11-06 | Hochstufung | CFRA | Hold → Buy |
2019-08-20 | Hochstufung | Susquehanna | Neutral → Positive |
2019-08-09 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
2019-08-06 | Herabstufung | Argus | Buy → Hold |
2019-08-05 | Herabstufung | SunTrust | Buy → Hold |
2019-07-12 | Herabstufung | Citigroup | Buy → Neutral |
2019-05-06 | Herabstufung | JP Morgan | Overweight → Neutral |
2019-04-15 | Hochstufung | SunTrust | Hold → Buy |
2019-02-19 | Herabstufung | Susquehanna | Positive → Neutral |
2019-01-08 | Eingeleitet | HSBC Securities | Buy |
2019-01-04 | Hochstufung | Citigroup | Neutral → Buy |
2018-11-02 | Herabstufung | Citigroup | Buy → Neutral |
2018-07-18 | Eingeleitet | RBC Capital Mkts | Outperform |
2018-01-30 | Eingeleitet | Morgan Stanley | Equal-Weight |
2017-12-06 | Herabstufung | Goldman | Buy → Neutral |
2017-08-07 | Hochstufung | UBS | Sell → Neutral |
Alle ansehen
Chemours Company Aktie (CC) Neueste Nachrichten
Millennium Management LLC Has $54.43 Million Position in The Chemours Company $CC - MarketBeat
Corebridge Financial Inc. Sells 163,238 Shares of The Chemours Company $CC - MarketBeat
Chemical giant dragged to court over shocking scandal in public drinking water: 'Exposed to real and ongoing harm' - yahoo.com
NCDEQ requires Chemours to expand PFAS well-testing to thousands in Cape Fear - Port City Daily
DEQ requires Chemours to expand PFAS well water testing - Coastal Review
NCDEQ mandates changes to PFAS well testing in the lower Cape Fear area - WHQR
Delivering Trusted Chemistry: A Year of Progress and Purpose - CSRwire
DEQ expands PFAS well testing to more areas in Southeastern NC - WWAYTV3
Can Chemours (CC) Board Refresh Shift Its Long-Term Strategy and Governance Approach? - simplywall.st
Medical Fluoropolymers Market Size, Top share, Demand | Industry Report, 2034 - Straits Research
NCDEQ requiring Chemours to expand well testing in the Lower Cape Fear - WECT
Chemours' Trusted Chemistry in Action: Driving Toward More Sustainable EV Batteries - CSRwire
Price jumps to $134 million to filter PFAS ‘forever chemicals’ from Fayetteville drinking water - CityView NC
Outstanding leadership: Steve Prusak of CPChem and Denise Dignam of Chemours - American Chemistry Council
The Chemours Company $CC Shares Purchased by Advisors Asset Management Inc. - MarketBeat
The Chemours Company (NYSE:CC) Receives $17.38 Average Price Target from Brokerages - MarketBeat
Lobbyists Cash In on Both Sides of PFAS Fight - readsludge.com
Chemours Appoints Mary Cranston as Board Chair, Names Alister Cowan Lead Independent Director - MSN
Chemours Gets Relative Strength Rating Upgrade - MSN
The Chemours Company $CC Shares Sold by Northern Trust Corp - MarketBeat
Chemours, India's SRF partner to boost fluoropolymer supply - Plastics News
SPONSORED How AI and other breakthroughs depend on chemistry - Axios
Can The Chemours Company expand into new marketsTrade Exit Summary & High Conviction Buy Zone Picks - Lancaster City Council
Europe Refrigerant Market Size & Growth Forecast 2025-2032: - openPR.com
EPA intends to rescind PFAS regulations as Chemours seeks to increase production - Port City Daily
Analysts Offer Insights on Materials Companies: Chemours Company (CC) and Ecolab (ECL) - The Globe and Mail
The Chemours Company Breaks Losing Streak — Is the Trend ReversingMarket Risk Summary & Daily Technical Forecast Reports - beatles.ru
Chemours names Mary Cranston as Chair - Indian Chemical News
Is The Chemours Company the Top Chart Pick This WeekTrade Entry Report & Free AI Powered Buy and Sell Recommendations - beatles.ru
A Look at Chemours’s Valuation Following Board Leadership Changes and Strategic Refresh - simplywall.st
Caption Management LLC Sells 117,980 Shares of The Chemours Company $CC - MarketBeat
Analyzing The Chemours Company with multi timeframe chartsMarket Trend Review & Accurate Trade Setup Notifications - Newser
How to monitor The Chemours Company with trend dashboardsPortfolio Growth Summary & Technical Buy Zone Confirmation - Newser
Highs Report: What are analysts’ price targets for The Chemours CompanyQuarterly Trade Report & Short-Term High Return Strategies - خودرو بانک
Is The Chemours Company stock bottoming outPortfolio Update Report & Growth Oriented Trading Recommendations - Newser
What to do if you’re stuck in The Chemours CompanyWeekly Gains Summary & Smart Money Movement Alerts - Newser
Chart based analysis of The Chemours Company trendsWeekly Trend Summary & Risk Controlled Daily Trade Plans - Newser
Is The Chemours Company stock entering bullish territoryWeekly Stock Summary & Long-Term Growth Stock Strategies - Newser
Chemours names Mary Cranston as Chair of the Board - MSN
VIX Spike: Is now the right time to enter The Chemours CompanyEarnings Recap Report & Real-Time Market Trend Scan - خودرو بانک
Is The Chemours Company in a consolidation phase2025 Key Lessons & Weekly Momentum Picks - خودرو بانک
Chart based exit strategy for The Chemours CompanyQuarterly Profit Summary & Long-Term Safe Investment Ideas - Newser
Has The Chemours Company formed a bullish divergenceTrade Signal Summary & Short-Term High Return Strategies - Newser
Khrom Capital Management LLC Sells 755,862 Shares of The Chemours Company $CC - MarketBeat
Pattern recognition hints at The Chemours Company upsideMarket Growth Report & Smart Allocation Stock Tips - Newser
Former Pillsbury CEO Tapped To Lead Chemours Board - Law360
Evaluating The Chemours Company with trendline analysisPortfolio Performance Report & Free Accurate Trade Setup Notifications - Newser
What MACD signals say about The Chemours CompanyQuarterly Trade Review & Free Low Drawdown Momentum Trade Ideas - Newser
Using RSI to spot recovery in The Chemours CompanyProduct Launch & Advanced Technical Signal Analysis - Newser
Will The Chemours Company benefit from macro trendsGold Moves & Safe Entry Zone Tips - Newser
How to build a custom watchlist for The Chemours CompanyOil Prices & Weekly Watchlist for Consistent Profits - Newser
Finanzdaten der Chemours Company-Aktie (CC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):